Nicotinic receptors aremembrane proteins involved in several physiological processes. They are considered suitable drug targets for various CNS disorders or conditions, as shown by the large number of compounds which have entered clinical trials. In recent years, nonconventional agonists have been discovered: positive allosteric modulators, allosteric agonists, site-specific agonists and silent desensitizers are compounds able to modulate the receptor interacting at sites different from the orthodox one, or to desensitize the receptor without prior opening. While these new findings can further complicate the pharmacology of these proteins and the design and optimization of ligands, they undoubtedly offer new opportunities to find drugs for the many therapeutic indications involving nicotinic receptors.
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities / Dina Manetti, Cristina Bellucci, Niccolo` Chiaramonte, Silvia Dei, Elisabetta Teodori, Maria Novella Romanelli. - In: FUTURE MEDICINAL CHEMISTRY. - ISSN 1756-8919. - STAMPA. - (2018), pp. 433-459. [10.4155/fmc-2017-0169]
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities
Dina Manetti;Cristina Bellucci;Niccolo` Chiaramonte;Silvia Dei;Elisabetta Teodori;Maria Novella Romanelli
2018
Abstract
Nicotinic receptors aremembrane proteins involved in several physiological processes. They are considered suitable drug targets for various CNS disorders or conditions, as shown by the large number of compounds which have entered clinical trials. In recent years, nonconventional agonists have been discovered: positive allosteric modulators, allosteric agonists, site-specific agonists and silent desensitizers are compounds able to modulate the receptor interacting at sites different from the orthodox one, or to desensitize the receptor without prior opening. While these new findings can further complicate the pharmacology of these proteins and the design and optimization of ligands, they undoubtedly offer new opportunities to find drugs for the many therapeutic indications involving nicotinic receptors.File | Dimensione | Formato | |
---|---|---|---|
submitted_pdf.pdf
Accesso chiuso
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Tutti i diritti riservati
Dimensione
819.55 kB
Formato
Adobe PDF
|
819.55 kB | Adobe PDF | Richiedi una copia |
REVIEW_rev_11.9_for DM submitted.pdf
accesso aperto
Tipologia:
Altro
Licenza:
Open Access
Dimensione
873.41 kB
Formato
Adobe PDF
|
873.41 kB | Adobe PDF | |
Future Medicinal Chmenistry reviewDesigning selective modulators for the nicotinic receptor subtypes challenges and opportunities.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
3.72 MB
Formato
Adobe PDF
|
3.72 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.